Abstract:Calreticulin (CRT), a luminal resident calcium-binding glycoprotein of the cell, is a tumor-associated antigen involved in tumorigenesis and also an autoantigen targeted by autoantibodies found in patients with various autoimmune diseases. We have previously shown that prokaryotically expressed recombinant murine CRT (rCRT) exhibits strong stimulatory activities against monocytes/macrophages in vitro and potent immunogenicity in vivo, which is partially attributable to self-oligomerization of soluble rCRT. However, even in oligomerized form native CRT (nCRT) isolated from mouse liver is much less active than rCRT, arguing against the possibility that self-oligomerization alone would license potent pro-inflammatory properties to nCRT. Since rCRT differs from nCRT in its lack of glycosylation, we wondered if aberrant glycosylation of eukaryotically expressed CRT (eCRT) would significantly enhance its immunological activity. In the present study, tunicamycin, an N-glycosyltransferase inhibitor, was employed to treat CHO cells (CHO-CRT) stably expressing full-length recombinant mouse CRT in secreted form for preparation of aberrantly glycosylated eCRT (tun-eCRT). Our biochemical and immunological analysis results indicate that eCRT produced by CHO-CRT cells is similar to nCRT in terms of glycosylation level, lack of self-oligomerization, relatively poor immunogenicity and weak macrophage-stimulatory activity, while tun-eCRT shows reduced glycosylation yet much enhanced ability to elicit specific humoral responses in mice and TNF-α and nitric oxide production by macrophages in vitro. Given that abberant glycosylation of proteins is a hallmark of cancer cells and also related to the development of autoimmune disorders in humans, our data may provide useful clues for better understanding of potentiating roles of dysregulated glycosylation of molecules such as CRT in tumorigenesis and autoimmunity.

Calreticulin functions in vitro as a molecular chaperone for both glycosylated and non-glycosylated proteins

Immunological Activities of Calreticulin

Self-Oligomerization Is Essential For Enhanced Immunological Activities Of Soluble Recombinant Calreticulin

Calreticulin—Enigmatic Discovery

Functional Analysis of Recombinant Calreticulin Fragment 39-272: Implications for Immunobiological Activities of Calreticulin in Health and Disease

Molecular Characterization of Calreticulin Gene in Mud Crabscylla Paramamosain(estampador): Implications for the Regulation of Calcium Homeostasis During Moult Cycle

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin.

Modulation of cellular immunity by antibodies against calreticulin.

A Conserved Basic Residue Cluster is Essential for the Protein Quality Control Function of Thearabidopsiscalreticulin 3

Immunological Activity Difference Between Native Calreticulin Monomers and Oligomers

Identification and characterization of calreticulin as a novel plasminogen receptor

Interaction of C1q with the Receptor Calreticulin Requires a Conformational Change in C1q

Chaperone-like effects of a scFv antibody on the folding of human muscle creatine kinase

Ca2+ Regulates ERp57-Calnexin Complex Formation

Calreticulin regulates hepatic stellate cell activation through modulating TGF-beta-induced Smad signaling.

The activities and function of molecular chaperones in the endoplasmic reticulum

Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum

Spectroscopic studies of 7,8-diacetoxy-4-methylcoumarin and 7,8-dipentynoyl-4-methylcoumarin binding with calreticulin

The Chaperonin TRiC/CCT Associates with Prefoldin through a Conserved Electrostatic Interface Essential for Cellular Proteostasis

Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum

Chaperone activity of Cyp18 through hydrophobic condensation that enables rescue of transient misfolded molten globule intermediates